Where is biological therapy going?
The substantial progress in our understanding of molecular and cellular biology has allowed us to design biological therapeutics ('biologicals') with defined targets and effector functions. These biologicals have greatly contributed to our current knowledge of pathogenetic mechanisms in autoimmune d...
Guardat en:
| Publicat a: | Arthritis Res |
|---|---|
| Autors principals: | , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
BMC
2000
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC130132/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/11094444/ https://ncbi.nlm.nih.govhttps://doi.org/10.1186/ar108 |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|